Mary Chaves

USPTO Granted Patents = 8 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 23(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421234 - Solid state forms (2025-09-23),

2. 12415806 - Solid state forms (2025-09-16),

3. 12398133 - Solid state forms (2025-08-26),

4. 12252486 - Solid state forms (2025-03-18),

5. 12187700 - Polymorphs and cocrystals of a cardiac troponin activator (2025-01-07),

6. 11827635 - Solid state forms (2023-11-28),

7. 11236091 - Solid state forms (2022-02-01),

8. 10053452 - Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine salts and uses thereof (2018-08-21),

Title: Mary Chaves: Innovator in Pharmaceutical Sciences

Introduction

Mary Chaves is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of pharmaceutical sciences, holding a total of 8 patents. Her work primarily focuses on the development of solid-state forms of pharmaceutical compounds.

Latest Patents

Mary Chaves' latest patents include innovative formulations of crystalline and amorphous forms of 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(2-propanyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl)pyrido[2,3-d]pyrimidin-2(1H)-one. These patents encompass several anhydrous, hydrate, and solvate forms, along with pharmaceutical compositions and methods for treating diseases mediated by KRAS G12C inhibition.

Career Highlights

Throughout her career, Mary has worked with leading companies in the pharmaceutical industry, including Amgen Inc. and Cytokinetics, Inc. Her expertise and innovative approach have positioned her as a key figure in her field.

Collaborations

Mary has collaborated with notable professionals such as Ron C Kelly and Darren Leonard Reid, contributing to advancements in pharmaceutical research and development.

Conclusion

Mary Chaves is a distinguished inventor whose work in pharmaceutical sciences has led to significant advancements in drug formulation and treatment methods. Her contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.